Previous Close
$1.21
Day Range
$0 - $0
Previous Day Range
$1.1603 - $1.23
Market Cap
$745.2 million USD
Day Vol.
0
Previous Day Vol.
14.0 million
Currency
USD
Primary Exchange
Nasdaq
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view